過敏性腸症候群治療薬のグローバル市場展望 2023年-2029年：IBS-D薬、IBS-C薬、その他

■ 英語タイトル：Irritable Bowel Syndrome Drug Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14378）

■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14378
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：65
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[過敏性腸症候群治療薬のグローバル市場展望 2023年-2029年：IBS-D薬、IBS-C薬、その他]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の過敏性腸症候群治療薬市場規模と予測を収録しています。・世界の過敏性腸症候群治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の過敏性腸症候群治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の過敏性腸症候群治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「IBS-D薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

過敏性腸症候群治療薬のグローバル主要企業は、Ironwood Pharmaceuticals、 Bausch Health、 Takeda、 Sebela Pharmaceuticals、 Allerganなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、過敏性腸症候群治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の過敏性腸症候群治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の過敏性腸症候群治療薬市場：タイプ別市場シェア、2022年
・IBS-D薬、IBS-C薬、その他

世界の過敏性腸症候群治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の過敏性腸症候群治療薬市場：用途別市場シェア、2022年
・女性、男性

世界の過敏性腸症候群治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の過敏性腸症候群治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における過敏性腸症候群治療薬のグローバル売上、2018年-2023年
・主要企業における過敏性腸症候群治療薬のグローバル売上シェア、2022年
・主要企業における過敏性腸症候群治療薬のグローバル販売量、2018年-2023年
・主要企業における過敏性腸症候群治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Ironwood Pharmaceuticals、 Bausch Health、 Takeda、 Sebela Pharmaceuticals、 Allergan

*************************************************************

・調査・分析レポートの概要
過敏性腸症候群治療薬市場の定義
市場セグメント
世界の過敏性腸症候群治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の過敏性腸症候群治療薬市場規模
世界の過敏性腸症候群治療薬市場規模：2022年 VS 2029年
世界の過敏性腸症候群治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの過敏性腸症候群治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の過敏性腸症候群治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：IBS-D薬、IBS-C薬、その他
過敏性腸症候群治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：女性、男性
過敏性腸症候群治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別過敏性腸症候群治療薬市場規模 2022年と2029年
地域別過敏性腸症候群治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Ironwood Pharmaceuticals、 Bausch Health、 Takeda、 Sebela Pharmaceuticals、 Allergan
...

This research report provides a comprehensive analysis of the Irritable Bowel Syndrome Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Irritable Bowel Syndrome Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Irritable Bowel Syndrome Drug, challenges faced by the industry, and potential opportunities for market players.
The global Irritable Bowel Syndrome Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Irritable Bowel Syndrome Drug market presents opportunities for various stakeholders, including Women, Men. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Irritable Bowel Syndrome Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global Irritable Bowel Syndrome Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Irritable Bowel Syndrome Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Irritable Bowel Syndrome Drug market.
Market Overview: The report provides a comprehensive overview of the Irritable Bowel Syndrome Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., IBS-D Drugs, IBS-C Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Irritable Bowel Syndrome Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Irritable Bowel Syndrome Drug market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Irritable Bowel Syndrome Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Irritable Bowel Syndrome Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Irritable Bowel Syndrome Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Irritable Bowel Syndrome Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Irritable Bowel Syndrome Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Irritable Bowel Syndrome Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Irritable Bowel Syndrome Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
IBS-D Drugs
IBS-C Drugs
Others
Market segment by Application
Women
Men
Global Irritable Bowel Syndrome Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Ironwood Pharmaceuticals
Bausch Health
Takeda
Sebela Pharmaceuticals
Allergan
Outline of Major Chapters:
Chapter 1: Introduces the definition of Irritable Bowel Syndrome Drug, market overview.
Chapter 2: Global Irritable Bowel Syndrome Drug market size in revenue.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Irritable Bowel Syndrome Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Irritable Bowel Syndrome Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Irritable Bowel Syndrome Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Irritable Bowel Syndrome Drug Overall Market Size
2.1 Global Irritable Bowel Syndrome Drug Market Size: 2022 VS 2029
2.2 Global Irritable Bowel Syndrome Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Irritable Bowel Syndrome Drug Players in Global Market
3.2 Top Global Irritable Bowel Syndrome Drug Companies Ranked by Revenue
3.3 Global Irritable Bowel Syndrome Drug Revenue by Companies
3.4 Top 3 and Top 5 Irritable Bowel Syndrome Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Irritable Bowel Syndrome Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Irritable Bowel Syndrome Drug Players in Global Market
3.6.1 List of Global Tier 1 Irritable Bowel Syndrome Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Irritable Bowel Syndrome Drug Market Size Markets, 2022 & 2029
4.1.2 IBS-D Drugs
4.1.3 IBS-C Drugs
4.1.4 Others
4.2 By Type – Global Irritable Bowel Syndrome Drug Revenue & Forecasts
4.2.1 By Type – Global Irritable Bowel Syndrome Drug Revenue, 2018-2023
4.2.2 By Type – Global Irritable Bowel Syndrome Drug Revenue, 2024-2029
4.2.3 By Type – Global Irritable Bowel Syndrome Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Irritable Bowel Syndrome Drug Market Size, 2022 & 2029
5.1.2 Women
5.1.3 Men
5.2 By Application – Global Irritable Bowel Syndrome Drug Revenue & Forecasts
5.2.1 By Application – Global Irritable Bowel Syndrome Drug Revenue, 2018-2023
5.2.2 By Application – Global Irritable Bowel Syndrome Drug Revenue, 2024-2029
5.2.3 By Application – Global Irritable Bowel Syndrome Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Irritable Bowel Syndrome Drug Market Size, 2022 & 2029
6.2 By Region – Global Irritable Bowel Syndrome Drug Revenue & Forecasts
6.2.1 By Region – Global Irritable Bowel Syndrome Drug Revenue, 2018-2023
6.2.2 By Region – Global Irritable Bowel Syndrome Drug Revenue, 2024-2029
6.2.3 By Region – Global Irritable Bowel Syndrome Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Irritable Bowel Syndrome Drug Revenue, 2018-2029
6.3.2 US Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.3.3 Canada Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.3.4 Mexico Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Irritable Bowel Syndrome Drug Revenue, 2018-2029
6.4.2 Germany Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.4.3 France Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.4.4 U.K. Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.4.5 Italy Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.4.6 Russia Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.4.7 Nordic Countries Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.4.8 Benelux Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Irritable Bowel Syndrome Drug Revenue, 2018-2029
6.5.2 China Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.5.3 Japan Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.5.4 South Korea Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.5.5 Southeast Asia Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.5.6 India Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Irritable Bowel Syndrome Drug Revenue, 2018-2029
6.6.2 Brazil Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.6.3 Argentina Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Irritable Bowel Syndrome Drug Revenue, 2018-2029
6.7.2 Turkey Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.7.3 Israel Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Irritable Bowel Syndrome Drug Market Size, 2018-2029
6.7.5 UAE Irritable Bowel Syndrome Drug Market Size, 2018-2029
7 Irritable Bowel Syndrome Drug Companies Profiles
7.1 Ironwood Pharmaceuticals
7.1.1 Ironwood Pharmaceuticals Company Summary
7.1.2 Ironwood Pharmaceuticals Business Overview
7.1.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Major Product Offerings
7.1.4 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Revenue in Global Market (2018-2023)
7.1.5 Ironwood Pharmaceuticals Key News & Latest Developments
7.2 Bausch Health
7.2.1 Bausch Health Company Summary
7.2.2 Bausch Health Business Overview
7.2.3 Bausch Health Irritable Bowel Syndrome Drug Major Product Offerings
7.2.4 Bausch Health Irritable Bowel Syndrome Drug Revenue in Global Market (2018-2023)
7.2.5 Bausch Health Key News & Latest Developments
7.3 Takeda
7.3.1 Takeda Company Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Irritable Bowel Syndrome Drug Major Product Offerings
7.3.4 Takeda Irritable Bowel Syndrome Drug Revenue in Global Market (2018-2023)
7.3.5 Takeda Key News & Latest Developments
7.4 Sebela Pharmaceuticals
7.4.1 Sebela Pharmaceuticals Company Summary
7.4.2 Sebela Pharmaceuticals Business Overview
7.4.3 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Major Product Offerings
7.4.4 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Revenue in Global Market (2018-2023)
7.4.5 Sebela Pharmaceuticals Key News & Latest Developments
7.5 Allergan
7.5.1 Allergan Company Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Irritable Bowel Syndrome Drug Major Product Offerings
7.5.4 Allergan Irritable Bowel Syndrome Drug Revenue in Global Market (2018-2023)
7.5.5 Allergan Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Irritable Bowel Syndrome Drug Market Opportunities & Trends in Global Market
Table 2. Irritable Bowel Syndrome Drug Market Drivers in Global Market
Table 3. Irritable Bowel Syndrome Drug Market Restraints in Global Market
Table 4. Key Players of Irritable Bowel Syndrome Drug in Global Market
Table 5. Top Irritable Bowel Syndrome Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Irritable Bowel Syndrome Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Irritable Bowel Syndrome Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Irritable Bowel Syndrome Drug Product Type
Table 9. List of Global Tier 1 Irritable Bowel Syndrome Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Irritable Bowel Syndrome Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Irritable Bowel Syndrome Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Irritable Bowel Syndrome Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Irritable Bowel Syndrome Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Irritable Bowel Syndrome Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Irritable Bowel Syndrome Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2024-2029
Table 30. Ironwood Pharmaceuticals Company Summary
Table 31. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Product Offerings
Table 32. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Ironwood Pharmaceuticals Key News & Latest Developments
Table 34. Bausch Health Company Summary
Table 35. Bausch Health Irritable Bowel Syndrome Drug Product Offerings
Table 36. Bausch Health Irritable Bowel Syndrome Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Bausch Health Key News & Latest Developments
Table 38. Takeda Company Summary
Table 39. Takeda Irritable Bowel Syndrome Drug Product Offerings
Table 40. Takeda Irritable Bowel Syndrome Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Takeda Key News & Latest Developments
Table 42. Sebela Pharmaceuticals Company Summary
Table 43. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Product Offerings
Table 44. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Sebela Pharmaceuticals Key News & Latest Developments
Table 46. Allergan Company Summary
Table 47. Allergan Irritable Bowel Syndrome Drug Product Offerings
Table 48. Allergan Irritable Bowel Syndrome Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Allergan Key News & Latest Developments
List of Figures
Figure 1. Irritable Bowel Syndrome Drug Segment by Type in 2022
Figure 2. Irritable Bowel Syndrome Drug Segment by Application in 2022
Figure 3. Global Irritable Bowel Syndrome Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Irritable Bowel Syndrome Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Irritable Bowel Syndrome Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Irritable Bowel Syndrome Drug Revenue in 2022
Figure 8. By Type - Global Irritable Bowel Syndrome Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Irritable Bowel Syndrome Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Irritable Bowel Syndrome Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Irritable Bowel Syndrome Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Irritable Bowel Syndrome Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Irritable Bowel Syndrome Drug Revenue Market Share, 2018-2029
Figure 16. US Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Irritable Bowel Syndrome Drug Revenue Market Share, 2018-2029
Figure 20. Germany Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Irritable Bowel Syndrome Drug Revenue Market Share, 2018-2029
Figure 28. China Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Irritable Bowel Syndrome Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Irritable Bowel Syndrome Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Irritable Bowel Syndrome Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bausch Health Irritable Bowel Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Takeda Irritable Bowel Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Allergan Irritable Bowel Syndrome Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

過敏性腸症候群治療薬のグローバル市場展望 2023年-2029年：IBS-D薬、IBS-C薬、その他

グローバル市場調査会社